Search Results - "Jouzeau, J Y"

Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis by Allen, P. B., Olivera, P., Emery, P., Moulin, D., Jouzeau, J.‐Y., Netter, P., Danese, S., Feagan, B., Sandborn, W. J., Peyrin‐Biroulet, L.

“…Summary Background Crohn's disease (CD) and rheumatoid arthritis are chronic, progressive and disabling conditions that frequently lead to structural tissue…”
Get full text

Association between adiponectin and cartilage degradation in human osteoarthritis by Francin, P.-J, Abot, A, Guillaume, C, Moulin, D, Bianchi, A, Gegout-Pottie, P, Jouzeau, J.-Y, Mainard, D, Presle, N

“…Summary Objective Conflicting findings raise questions about the role of adiponectin in osteoarthritis (OA). The current study aimed to investigate in OA…”
Get full text

Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity by Abed, E, Bouvard, B, Martineau, X, Jouzeau, J.-Y, Reboul, P, Lajeunesse, D

“…Abstract Purpose Clinical and in vitro studies suggest that subchondral bone sclerosis due to abnormal osteoblasts is involved in the progression of…”
Get full text

Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a klotho-independent manner by Bianchi, Arnaud, Guibert, Mathilde, Cailotto, Frédéric, Gasser, Adeline, Presle, Nathalie, Mainard, Didier, Netter, Patrick, Kempf, Hervé, Jouzeau, Jean-Yves, Reboul, Pascal

“…Summary Objective Fibroblast Growth Factor 23 (FGF23) may represent an attractive candidate that could participate to the osteoarthritic (OA)-induced phenotype…”
Get full text

Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypes by Maumus, M., Noël, D., Ea, H.K., Moulin, D., Ruiz, M., Hay, E., Houard, X., Cleret, D., Cohen-Solal, M., Jacques, C., Jouzeau, J.-Y., Lafage-Proust, M.-H., Reboul, P., Sellam, J., Vinatier, C., Rannou, F., Jorgensen, C., Guicheux, J., Berenbaum, F.

“…TGFβ is a key player in cartilage homeostasis and OA pathology. However, few data are available on the role of TGFβ signalling in the different OA phenotypes…”
Get full text

Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis by Dumond, H., Presle, N., Pottie, P., Pacquelet, S., Terlain, B., Netter, P., Gepstein, A., Livne, E., Jouzeau, J.-Y.

“…Objectives: To characterize the molecular events underlying cartilage injury in the early phase of mono-iodoacetate-induced osteoarthritis (OA) in rats…”
Get full text

Identification of new microRNAs targeting genes regulating the Pi/PPi balance in chondrocytes by Clement, T, Salone, V, Charpentier, B, Jouzeau, J-Y, Bianchi, A

“…Osteoarthritis (OA) is a whole-joint disease characterized by cartilage degradation and mineralization associated with chondrocyte phenotype changes,…”
Get more information

Cytocompatibility of Ti-6Al-4V and Ti-5Al-2.5Fe alloys according to three surface treatments, using human fibroblasts and osteoblasts by Bordji, K., Jouzeau, J.Y., Mainard, D., Payan, E., Netter, P., Rie, K.T., Stucky, T., Hage-Ali, M.

“…Titanium alloys are well known for their superior mechanical properties as well as for their good biocompatibility, making them desirable as surgical implant…”
Get full text

Cyclo-oxygenase isoenzymes : How recent findings affect thinking about nonsteroidal anti-inflammatory drugs by JOUZEAU, J.-Y, TERLAIN, B, ABID, A, NEDELEC, E, NETTER, P

“…The discovery of at least 2 cyclo-oxygenase (COX) isoenzymes, referred to as COX-1 and COX-2, has updated our knowledge of nonsteroidal anti-inflammatory drugs…”
Get full text

Plasma surface treatment and PACVD on Ti alloys for surgical implants by Rie, K.-T., Stucky, T., Silva, R.A., Leit≈ao, E., Bordji, K., Jouzeau, J.-Y., Mainard, D.

“…To improve the poor surface hardness and wear resistance of titanium alloys used for surgical implants undergoing wear TiA16V4 and TiA15Fe2.5 have been plasma…”
Get full text

Evidence for species differences in the regulation of MMPs by all-trans retinoic acid in cytokine-stimulated chondrocytes by Kirchmeyer, M, Deffaud, J, Sebillaud, S, Moulin, D, Koufany, M, Netter, P, Bianchi, A, Jouzeau, J-Y

“…In inflammatory conditions, chondrocytes produce large amounts of matrix metalloproteases (MMP) and nitric oxide (NO) thought to contribute to joint…”
Get more information

Separation and Quantification by Ion-Association Capillary Zone Electrophoresis of Unsaturated Disaccharide Units of Chondroitin Sulfates and Oligosaccharides Derived from Hyaluronan by Payan, E, Presle, N, Lapicque, F, Jouzeau, J. Y, Bordji, K, Oerther, S, Miralles, G, Mainard, D, Netter, P

“…An analytical method has been developed for assay of unsaturated disaccharides of chondroitin sulfates and of oligosaccharides (tetra- and hexasaccharides) of…”
Get full text

Oxidative stress-induced expression of HSP70 contributes to the inhibitory effect of 15d-PGJ2 on inducible prostaglandin pathway in chondrocytes by Bianchi, A, Moulin, D, Hupont, S, Koufany, M, Netter, P, Reboul, P, Jouzeau, J-Y

“…The inhibitory effect of 15-deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) on proinflammatory gene expression has been extensively documented and frequently…”
Get full text

Modulation of IL‐1‐induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities by Cipolletta, Christine, Jouzeau, Jean‐Yves, Gegout‐Pottie, Pascale, Presle, Nathalie, Bordji, Karim, Netter, Patrick, Terlain, Bernard

“…Nitric oxide (NO) is produced in diseased joints and may be a key mediator of IL‐1 effects on cartilage. Therefore, we compared the potency of new…”
Get full text

Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization by Abed, É, Bouvard, B, Delalandre, A, Jouzeau, J.-Y, Reboul, P, Lajeunesse, D

Get full text

Modulation of IL-1 effects on cartilage by NO synthase inhibitors: pharmacological studies in rats by Jouzeau, J.-Y, Cipolletta, C, Presle, N, Netter, P, Terlain, B

“…Objective To compare the ability of L-arginine (L-arg) analog nitric oxide synthase (NOS) inhibitors and isothioureas to restore the interleukin-1 (IL-1)…”
Get full text

Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes by Poleni, P E, Bianchi, A, Etienne, S, Koufany, M, Sebillaud, S, Netter, P, Terlain, B, Jouzeau, J Y

“…To investigate the potency of selective agonists of peroxisome proliferators-activated receptors' (PPAR) isotypes (alpha, beta/delta or gamma) to modulate the…”
Get full text

miR-29b is overexpressed in osteoarthritic patients and targets type II collagen by Moulin, D, Salone, V, Koufany, M, Clement, T, Netter, P, Behm-Ansmant, I, Charpentier, B, Branlant, C, Jouzeau, J.-Y

Get full text

Agonists of peroxisome proliferators-activated receptors (PPAR) α, β/δ or γ reduce transforming growth factor (TGF)-β-induced proteoglycans' production in chondrocytes by Poleni, P.E., M.Sc, Bianchi, A., Ph.D, Etienne, S., M.Sc, Koufany, M., B.Sc, Sebillaud, S., B.Sc, Netter, P., M.D., Ph.D, Terlain, B., Pharm.D, Jouzeau, J.Y., Pharm.D., Ph.D

“…Summary Objective To investigate the potency of selective agonists of peroxisome proliferators-activated receptors' (PPAR) isotypes (α, β/δ or γ) to modulate…”
Get full text

208 CALCIUM INPUT MODULATES TRANSFORMING GROWTH FACTOR-β1-INDUCED EXPORT OF INORGANIC PYROPHOSPHATE BY CONTROLLING ANK EXPRESSION IN CHONDROCYTE: POSSIBLE INSIGHT TO THE PATHOPHYSIOLOGY OF HYPERCALCEMIA-RELATED CHONDROCALCINOSIS by Cailotto, F, Sebillaud, S, Reboul, P, Netter, P, Jouzeau, J.-Y, Bianchi, A

Get full text